Oklo shares fall 7.7% as analysts cut targets after Q2 results
Oklo Inc. delivered strong Q2 revenue of $1.21 million, significantly beating analyst estimates, but reported a wider-than-expected EPS loss of $(0.28). This performance led to a 7.7% drop in share price to $44.70 and prompted analysts from Canaccord Genuity and Citigroup to lower their price targets. Despite the near-term earnings miss, Oklo maintains a strong balance sheet with $1.6 billion in cash to fund its 2026 capital expenditure plans of $400 million to $500 million.
*this image is generated using AI for illustrative purposes only.
Oklo Inc. (NYSE: OKLO) reported second-quarter 2026 revenue of $1.21 million on August 7, 2026, significantly exceeding the analyst consensus estimate of $126,250 by 858.42 percent. Despite this top-line beat, the advanced nuclear technology company recorded a quarterly loss of $(0.28) per share, missing the analyst estimate of $(0.16) per share by 75 percent. The widening loss reflects the capital-intensive nature of its development phase, where operational costs currently outpace revenue generation.
The market reacted negatively to the earnings miss and broader valuation concerns. Oklo shares fell 7.7 percent to trade at $44.70 on Monday. Following the announcement, several analysts adjusted their outlooks:
- Canaccord Genuity analyst George Gianarikas maintained a Buy rating but lowered the price target from $125 to $100.
- Citigroup analyst Vikram Bagri maintained a Neutral rating and lowered the price target from $76 to $57.5.
- HC Wainwright & Co. analyst Sameer Joshi reiterated a Buy rating with an unchanged $90 price target.
Financial Performance Overview
Oklo ended the quarter with a robust balance sheet, holding $1.6 billion in cash and cash equivalents. For the full year 2026, the company expects operating cash flow of $120 million to $150 million. Capital expenditures for property, plant, and equipment are projected at $400 million to $500 million. Co-founder and Chief Executive Officer Jacob DeWitte and Chief Financial Officer Craig Bealmear discussed these results during a conference call held on August 7, 2026.
| Metric | Actual | Estimate / Prior Year | Variance |
|---|---|---|---|
| Sales | $1.21 million | $126,250 (Estimate) | +858.42% vs Estimate |
| EPS Loss | $(0.28) | $(0.16) (Estimate) | -75% vs Estimate |
| YoY EPS Change | $(0.28) | $(0.18) (Prior Year) | -55.56% decrease |
Aurora Powerhouse Regulatory Progress
Oklo remains focused on deploying its first Aurora powerhouse by 2028. The company secured a site use permit from the U.S. Department of Energy (DOE) for the Idaho National Laboratory (INL) location. Additionally, Oklo received a fuel allocation of five metric tons of High-Assay Low-Enriched Uranium (HALEU) produced from recovered uranium at INL for a commercial Aurora powerhouse in Idaho.
As part of the construction and operating approval process, Oklo submitted the Nuclear Safety Design Agreement and Preliminary Documented Safety Analysis (PDSA) for the Aurora-INL project. These documents represent two of the five stages in the DOE’s regulatory pathway for nuclear facility operations.
Strategic Partnerships and Customer Pipeline
During the quarter, Oklo announced AI-focused collaborations with NVIDIA, Los Alamos National Laboratory, and Battelle Energy Alliance. These partnerships aim to advance AI-enabled reactor design, simulation, fuel development, engineering workflows, and its Pluto reactor system under the DOE’s Reactor Pilot Program.
The company continues to expand its customer pipeline across multiple industries:
- Signed non-binding letters of intent with Equinix, Diamondback Energy, and Prometheus Hyperscale.
- Secured a 12 GW Master Power Agreement with Switch in December 2024, one of the largest corporate power purchase agreements to date.
- Entered a prepayment agreement with Meta in January 2026 to support the development of a 1.2 GW power campus in Ohio for Meta’s data centers.
- Signed a letter of intent with Centrus Energy in June 2026 for potential HALEU fuel supply to support up to five Aurora powerhouses, with deliveries expected from 2029.
What the Numbers Show
The data reveals a stark contrast between revenue generation and cost management. While the 858.42 percent beat on sales suggests successful commercial activity or project ramp-ups, the 75 percent miss on EPS indicates that operating expenses or other costs increased at a faster rate than revenue. The fact that the EPS loss widened by 55.56 percent year-over-year further underscores that the company is investing heavily or facing higher operational burdens during this growth phase. However, the $1.6 billion cash position provides substantial runway to fund the projected $400 million to $500 million in capital expenditures while navigating the long lead times associated with nuclear regulatory approvals.
How will Oklo's projected $400M-$500M in capital expenditures impact its cash runway and potential need for future dilutive financing before reaching profitability?
What specific regulatory milestones must Oklo achieve between now and 2028 to maintain confidence in its Aurora powerhouse deployment timeline?
Given the widening EPS miss, are there indications that Oklo's operating cost structure is scalable, or will margins remain compressed during the initial commercial rollout phase?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
